AT251624B
(de)
|
1962-05-02 |
1967-01-10 |
Knapsack Ag |
Ferrosilizium als Desoxydations-, Schlackenreduktions-, Impf- und/oder Legierungsmittel
|
DE2623228C3
(de)
|
1976-05-24 |
1981-09-10 |
Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren |
N-Acyl-substituierte Benzamide, Verfahren zu ihrer Herstellung und Arzneimittel, enthaltend solche Benzamide
|
JPS5587771A
(en)
|
1978-12-27 |
1980-07-02 |
Teikoku Hormone Mfg Co Ltd |
1-phenylisoquinoline derivative
|
US4456757A
(en)
|
1981-03-20 |
1984-06-26 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Isoquinolinesulfonyl derivatives and process for the preparation thereof
|
JPS5993054A
(ja)
|
1982-11-18 |
1984-05-29 |
Asahi Chem Ind Co Ltd |
イソキノリンスルホン酸アミド誘導体
|
DK8386A
(da)
|
1986-01-15 |
1987-07-09 |
Tpo Pharmachim |
Nye n-substituerede 1-benzyl-2-carbamoyltetrahydroisoquinoliner og fremgangsmaade til fremstilling af samme
|
US4911928A
(en)
|
1987-03-13 |
1990-03-27 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
US5591887A
(en)
|
1987-04-30 |
1997-01-07 |
R-Tech Ueno, Ltd. |
Prostaglandins of the F series
|
JPH01139528A
(ja)
|
1987-11-24 |
1989-06-01 |
Showa Denko Kk |
抗潰瘍剤
|
DE68913000T3
(de)
|
1988-09-06 |
2004-10-21 |
Pharmacia Ab |
Prostaglandinderivate zur Behandlung des grünen Stars oder einer okularen Hypertension.
|
EP0389995B1
(en)
|
1989-03-28 |
1995-05-31 |
Nisshin Flour Milling Co., Ltd. |
Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension
|
KR920008026A
(ko)
|
1990-10-24 |
1992-05-27 |
오노 화아마슈티칼 캄파니 리미팃드 |
이소퀴놀리논 유도체 또는 이의 무독성 산부가염 또는 이의 수화물, 이의 제조방법 및 이를 포함하는 약제 조성물
|
US5508288A
(en)
|
1992-03-12 |
1996-04-16 |
Smithkline Beecham, P.L.C. |
Indole derivatives as 5HT1C antagonists
|
US5972991A
(en)
|
1992-09-21 |
1999-10-26 |
Allergan |
Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
DE4332168A1
(de)
|
1993-02-22 |
1995-03-23 |
Thomae Gmbh Dr K |
Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
US5510383A
(en)
|
1993-08-03 |
1996-04-23 |
Alcon Laboratories, Inc. |
Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
|
US6124344A
(en)
|
1993-12-28 |
2000-09-26 |
Allergan Sales, Inc. |
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
US5462968A
(en)
|
1994-01-19 |
1995-10-31 |
Allergan, Inc. |
EP2 -receptor agonists as agents for lowering intraocular pressure
|
US5698733A
(en)
|
1994-09-30 |
1997-12-16 |
Alcon Laboratories, Inc. |
Use of 9-deoxy prostaglandin derivatives to treat glaucoma
|
US6169111B1
(en)
|
1995-06-07 |
2001-01-02 |
Alcon Laboratories, Inc. |
Conformationally rigid aryl prostaglandins for use in glaucoma therapy
|
US5866602A
(en)
|
1995-12-22 |
1999-02-02 |
Alcon Laboratories, Inc. |
Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
|
US5814660A
(en)
|
1995-12-22 |
1998-09-29 |
Alcon Laboratories, Inc. |
9-oxa prostaglandin analogs as ocular hypotensives
|
EP0869794B1
(en)
|
1995-12-22 |
2004-08-11 |
Alcon Laboratories, Inc. |
Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
|
US6586425B2
(en)
|
1996-02-21 |
2003-07-01 |
Wisconsin Alumni Research Foundation |
Cytoskeletal active agents for glaucoma therapy
|
US5798380A
(en)
|
1996-02-21 |
1998-08-25 |
Wisconsin Alumni Research Foundation |
Cytoskeletal active agents for glaucoma therapy
|
EP0930296B2
(en)
|
1996-09-17 |
2005-11-02 |
Asahi Glass Company Ltd. |
Fluorinated prostaglandin derivatives and medicines
|
US6353014B1
(en)
|
1996-11-12 |
2002-03-05 |
Alcon Laboratories, Inc. |
15-ketal postaglandins for the treatment of glaucoma or ocular hypertension
|
US6235779B1
(en)
|
1996-11-12 |
2001-05-22 |
Alcon Laboratories, Inc. |
Use of cis-Δ4 analogs of prostaglandins as ocular hypotensives
|
AU5436198A
(en)
|
1996-11-12 |
1998-06-03 |
Alcon Laboratories, Inc. |
11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
|
EP0938472B1
(en)
|
1996-11-12 |
2001-06-27 |
Alcon Laboratories, Inc. |
15-fluoro prostaglandins as ocular hypotensives
|
EP0968183A2
(en)
|
1997-03-07 |
2000-01-05 |
Alcon Laboratories, Inc. |
13-thia prostaglandins for use in glaucoma therapy
|
WO1998050024A1
(en)
|
1997-05-09 |
1998-11-12 |
The Mount Sinai School Of Medicine Of The City University Of New York |
8-iso-prostaglandins for glaucoma therapy
|
US5891646A
(en)
|
1997-06-05 |
1999-04-06 |
Duke University |
Methods of assaying receptor activity and constructs useful in such methods
|
SE9702706D0
(sv)
|
1997-07-11 |
1997-07-11 |
Pharmacia & Upjohn Ab |
Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
|
WO2000077027A2
(en)
|
1999-06-14 |
2000-12-21 |
Tularik Limited |
Serine protease inhibitors
|
IL134840A0
(en)
|
1997-09-09 |
2001-05-20 |
Procter & Gamble |
Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
|
EP1012136B1
(en)
|
1997-09-09 |
2004-07-07 |
Duke University |
Aromatic c 16?-c 20?-substituted tetrahydro prostaglandins useful as fp agonists
|
AU741014B2
(en)
|
1997-09-09 |
2001-11-22 |
Duke University |
Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists
|
US5877211A
(en)
|
1997-11-21 |
1999-03-02 |
Allergan |
EP2 receptor agonists as neuroprotective agents for the eye
|
WO1999032441A1
(en)
|
1997-12-22 |
1999-07-01 |
Alcon Laboratories, Inc. |
13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension
|
PT1011728E
(pt)
|
1998-07-14 |
2005-03-31 |
Alcon Mfg Ltd |
Recipientes de polipropileno para produtos de prostaglandina
|
TWI249520B
(en)
|
1998-07-15 |
2006-02-21 |
Ono Pharmaceutical Co |
5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
|
US6720175B1
(en)
|
1998-08-18 |
2004-04-13 |
The Johns Hopkins University School Of Medicine |
Nucleic acid molecule encoding homer 1B protein
|
US20020065296A1
(en)
|
1999-01-13 |
2002-05-30 |
Bayer Corporation |
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
|
JP2003500385A
(ja)
|
1999-05-24 |
2003-01-07 |
コア・セラピューティクス,インコーポレイテッド |
Xa因子阻害剤
|
ES2342344T3
(es)
|
1999-11-26 |
2010-07-05 |
SHIONOGI & CO., LTD. |
Antagonistas de npy-y5.
|
KR100641802B1
(ko)
|
1999-12-28 |
2006-11-02 |
에자이 가부시키가이샤 |
술폰아미드 함유 복소환 화합물
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
HN2001000008A
(es)
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
DE60141889D1
(de)
|
2000-02-03 |
2010-06-02 |
Eisai R&D Man Co Ltd |
Inhibitoren der integrinexpression
|
US6410566B1
(en)
|
2000-05-16 |
2002-06-25 |
Teijin Limited |
Cyclic amine derivatives and their use as drugs
|
US6908741B1
(en)
|
2000-05-30 |
2005-06-21 |
Transtech Pharma, Inc. |
Methods to identify compounds that modulate RAGE
|
US6855690B2
(en)
*
|
2000-06-01 |
2005-02-15 |
Children's Medical Center Corporation |
Methods and compositions for treating ocular disorders
|
US6323228B1
(en)
|
2000-09-15 |
2001-11-27 |
Abbott Laboratories |
3-substituted indole angiogenesis inhibitors
|
DE60141849D1
(de)
|
2000-10-17 |
2010-05-27 |
Merck Serono Sa Coinsins |
Pharmazeutisch aktive sulfonamid-derivate
|
US7163800B2
(en)
|
2000-11-03 |
2007-01-16 |
Molecular Devices Corporation |
Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
|
CA2440037C
(en)
|
2001-03-05 |
2010-02-16 |
Transtech Pharma, Inc. |
Benzimidazole derivatives for modulating the rage receptor
|
MXPA03009648A
(es)
|
2001-04-20 |
2005-10-05 |
Bayer Ag |
Inhibicion de raf cinasa usando quinolinil, isoquinolinil, o piridil ureas.
|
US6956035B2
(en)
|
2001-08-31 |
2005-10-18 |
Inotek Pharmaceuticals Corporation |
Isoquinoline derivatives and methods of use thereof
|
ES2305435T3
(es)
|
2002-01-10 |
2008-11-01 |
Bayer Healthcare Ag |
Inhibidores de la rho-quinasa.
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
DE60325025D1
(de)
|
2002-02-15 |
2009-01-15 |
Glaxo Group Ltd |
Modulatoren des vanilloidrezeptors
|
AU2003217870A1
(en)
|
2002-03-01 |
2003-09-16 |
Pintex Pharmaceuticals, Inc. |
Pini-modulating compounds and methods of use thereof
|
EP2324830A1
(en)
|
2002-03-05 |
2011-05-25 |
TransTech Pharma Inc. |
Process for the preparation of a monocyclic azole derivative that inhibits the interaction of ligands with rage
|
GB0206876D0
(en)
|
2002-03-22 |
2002-05-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
US7645878B2
(en)
|
2002-03-22 |
2010-01-12 |
Bayer Healthcare Llc |
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
|
AU2003228956B2
(en)
|
2002-05-13 |
2009-10-01 |
Mds Analytical Technologies (Us) Inc. |
Constitutively translocating cell line
|
US20050245509A1
(en)
|
2002-08-29 |
2005-11-03 |
Santen Pharmacecutical Co., Ltd. |
Remedy for glaucoma comprising rho kinase inhibitor and prostaglandins
|
JP4482726B2
(ja)
*
|
2002-08-29 |
2010-06-16 |
参天製薬株式会社 |
Rhoキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤
|
CA2496891A1
(en)
|
2002-08-30 |
2004-03-18 |
Anges Mg, Inc. |
Novel actin-related cytoskeletal protein lacs
|
CA2502583A1
(en)
|
2002-09-12 |
2004-03-25 |
Kirin Beer Kabushiki Kaisha |
Isoquinoline derivatives having kinase inhibitory activity and medicament containing the same
|
US7495016B2
(en)
|
2002-10-21 |
2009-02-24 |
Irm Llc |
Pyrrolidones with anti-HIV activity
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
JP4400566B2
(ja)
|
2003-06-12 |
2010-01-20 |
アステラス製薬株式会社 |
ベンズアミド誘導体又はその塩
|
WO2005020921A2
(en)
|
2003-08-29 |
2005-03-10 |
Exelixis, Inc. |
C-kit modulators and methods of use
|
JP2007507547A
(ja)
|
2003-10-06 |
2007-03-29 |
グラクソ グループ リミテッド |
キナーゼ阻害剤としての1,7−二置換アザベンゾイミダゾールの調製
|
JP2007008816A
(ja)
|
2003-10-15 |
2007-01-18 |
Ube Ind Ltd |
新規イソキノリン誘導体
|
DE10348023A1
(de)
|
2003-10-15 |
2005-05-19 |
Imtm Gmbh |
Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
KR101163800B1
(ko)
|
2003-10-15 |
2012-07-09 |
산텐 세이야꾸 가부시키가이샤 |
신규 인다졸 유도체
|
SE0400284D0
(sv)
|
2004-02-10 |
2004-02-10 |
Astrazeneca Ab |
Novel compounds
|
JP2005227441A
(ja)
|
2004-02-12 |
2005-08-25 |
Konica Minolta Medical & Graphic Inc |
光熱写真画像形成材料
|
WO2005082890A1
(en)
|
2004-02-20 |
2005-09-09 |
Smithkline Beecham Corporation |
Novel compounds
|
US20080096238A1
(en)
|
2004-03-30 |
2008-04-24 |
Alcon, Inc. |
High throughput assay for human rho kinase activity with enhanced signal-to-noise ratio
|
DE102004017438A1
(de)
|
2004-04-08 |
2005-11-03 |
Bayer Healthcare Ag |
Hetaryloxy-substituierte Phenylaminopyrimidine
|
US7453002B2
(en)
|
2004-06-15 |
2008-11-18 |
Bristol-Myers Squibb Company |
Five-membered heterocycles useful as serine protease inhibitors
|
EP1756092A4
(en)
|
2004-06-17 |
2009-12-02 |
Smithkline Beecham Corp |
NEW INHIBITORS OF RHO-KINASEN
|
DK1607840T3
(da)
|
2004-06-18 |
2015-02-16 |
Tobii Technology Ab |
Øjenstyring af et computerapparat
|
PL1786785T3
(pl)
|
2004-08-26 |
2010-08-31 |
Pfizer |
Enancjomerycznie czyste związki aminoheteroarylowe jako kinazy białkowe
|
JP4478157B2
(ja)
|
2004-10-13 |
2010-06-09 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ヒドラジド誘導体
|
UY29198A1
(es)
|
2004-11-09 |
2006-05-31 |
Cancer Rec Tech Ltd |
Derivados sustituidos de quinazolinona y derivados sustituidos de quinazolina-2, 4-diona, composiciones conteniéndolos, procedimientos de preparación y aplicaciones
|
GB0425026D0
(en)
|
2004-11-12 |
2004-12-15 |
Biofocus Discovery Ltd |
Compounds which bind to the active site of protein kinase enzymes
|
CA2589271A1
(en)
|
2004-12-07 |
2006-06-15 |
Locus Pharmaceuticals, Inc. |
Urea inhibitors of map kinases
|
EP1833832A1
(en)
|
2004-12-31 |
2007-09-19 |
GPC Biotech AG |
Napthyridine compounds as rock inhibitors
|
US7652041B2
(en)
|
2005-01-14 |
2010-01-26 |
Millennium Pharmaceuticals, Inc. |
Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity
|
WO2006081554A2
(en)
|
2005-01-28 |
2006-08-03 |
Irm Llc |
Phenyl-substituted pyrrolidones
|
EP1851197A2
(en)
|
2005-02-09 |
2007-11-07 |
Microbia, Inc. |
Phenylazetidinone derivatives
|
CA2608589A1
(en)
|
2005-05-25 |
2006-11-30 |
Wyeth |
Methods of synthesizing 6-alkylaminoquinoline derivatives
|
US20070135499A1
(en)
|
2005-07-11 |
2007-06-14 |
Aerie Pharmaceuticals, Inc. |
Hydrazide compounds
|
EP1910297B1
(en)
|
2005-07-11 |
2016-05-25 |
Aerie Pharmaceuticals, Inc. |
Isoquinoline compounds
|
EP1951253A2
(en)
|
2005-10-26 |
2008-08-06 |
Cotherix, Inc. |
Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
|
TW200738682A
(en)
|
2005-12-08 |
2007-10-16 |
Organon Nv |
Isoquinoline derivatives
|
RU2008130111A
(ru)
|
2005-12-22 |
2010-01-27 |
Алькон Рисерч, Лтд. (Us) |
(индазол-5-ил)пиразины и (1,3-дигидроиндол-2-он)пиразины для лечения опосредованнызх rно-киназой заболеваний и состояний
|
AR057252A1
(es)
|
2005-12-27 |
2007-11-21 |
Alcon Mfg Ltd |
Inhibicion de rho quinasa mediada por arni para el tratamiento de trastornos oculares
|
US8129411B2
(en)
|
2005-12-30 |
2012-03-06 |
Novartis Ag |
Organic compounds
|
US8012966B2
(en)
|
2006-01-27 |
2011-09-06 |
Shanghai Hengrui Pharmaceutical Co., Ltd. |
Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
|
JP5476559B2
(ja)
|
2006-02-10 |
2014-04-23 |
国立大学法人九州大学 |
リン酸化酵素の新規基質ポリペプチド
|
US7625927B2
(en)
*
|
2006-02-27 |
2009-12-01 |
Alcon Research, Ltd. |
Method of treating glaucoma
|
JP2009528365A
(ja)
|
2006-02-28 |
2009-08-06 |
アムゲン インコーポレイティッド |
ホスホジエステラーゼ10阻害剤としてのシンノリン及びキナゾリン誘導体
|
JP2007246466A
(ja)
|
2006-03-17 |
2007-09-27 |
Osaka Univ |
中枢神経損傷に対する嗅粘膜移植にRhoキナーゼ阻害剤を用いた神経機能再建法
|
EP2025676A4
(en)
|
2006-06-08 |
2011-06-15 |
Ube Industries |
NEW INDAZONE DERIVATIVE WITH SPIRING STRUCTURE IN SIDE CHAIN
|
CA2658764A1
(en)
|
2006-07-20 |
2008-01-24 |
Mehmet Kahraman |
Benzothiophene inhibitors of rho kinase
|
US20090318485A1
(en)
|
2006-07-20 |
2009-12-24 |
Kalypsys, Inc. |
Novel inhibitors of rho kinase
|
WO2008016016A1
(en)
|
2006-07-31 |
2008-02-07 |
Senju Pharmaceutical Co., Ltd. |
Aqueous liquid preparation containing amide compound
|
WO2008036540A2
(en)
|
2006-09-20 |
2008-03-27 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
WO2008054599A2
(en)
|
2006-09-27 |
2008-05-08 |
Surface Logix, Inc. |
Rho kinase inhibitors
|
WO2008044700A1
(fr)
|
2006-10-11 |
2008-04-17 |
Takeda Pharmaceutical Company Limited |
INHIBITEUR DE LA GSK-3β
|
US8949825B1
(en)
|
2006-10-17 |
2015-02-03 |
Manageiq, Inc. |
Enforcement of compliance policies in managed virtual systems
|
US20090036465A1
(en)
|
2006-10-18 |
2009-02-05 |
United Therapeutics Corporation |
Combination therapy for pulmonary arterial hypertension
|
WO2008049919A2
(en)
|
2006-10-26 |
2008-05-02 |
Devgen N.V. |
Rho kinase inhibitors
|
US8071779B2
(en)
|
2006-12-18 |
2011-12-06 |
Inspire Pharmaceuticals, Inc. |
Cytoskeletal active rho kinase inhibitor compounds, composition and use
|
WO2008079945A2
(en)
|
2006-12-20 |
2008-07-03 |
University Of South Florida |
Rock inhibitors and uses thereof
|
AR064420A1
(es)
|
2006-12-21 |
2009-04-01 |
Alcon Mfg Ltd |
Composiciones farmaceuticas oftalmicas que comprenden una cantidad efectiva de analogos de 6-aminoimidazo[1,2b]piridazinas, utiles para el tratamiento del glaucoma y/o controlar la presion intraocular normal o elevada(iop).
|
MX2009005828A
(es)
|
2006-12-27 |
2009-06-16 |
Sanofi Aventis |
Derivados de isoquinolona e isoquinolinona sustituidos con cicloalquilamina.
|
RU2455302C2
(ru)
|
2006-12-27 |
2012-07-10 |
Санофи-Авентис |
ЗАМЕЩЕННЫЕ ИЗОХИНОЛИНОВЫЕ И ИЗОХИНОЛИНОНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Rho-КИНАЗЫ
|
DE602007013295D1
(de)
|
2006-12-27 |
2011-04-28 |
Sanofi Aventis |
Substituierte isochinoline und ihre verwendung als rho-kinase-inhibitoren
|
JP5405316B2
(ja)
|
2006-12-27 |
2014-02-05 |
サノフイ |
シクロアルキルアミン置換イソキノリン誘導体
|
JP5405315B2
(ja)
|
2006-12-27 |
2014-02-05 |
サノフイ |
置換イソキノリン及びイソキノリノン誘導体
|
JP5318779B2
(ja)
|
2006-12-27 |
2013-10-16 |
サノフイ |
シクロアルキルアミン置換イソキノリン及びイソキノリノン誘導体
|
KR101474228B1
(ko)
|
2006-12-27 |
2014-12-18 |
사노피 |
사이클로알킬아민 치환된 이소퀴놀론 유도체
|
US8455513B2
(en)
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
US8415372B2
(en)
|
2007-02-27 |
2013-04-09 |
Asahi Kasei Pharma Corporation |
Sulfonamide compound
|
CA2683647A1
(en)
|
2007-04-10 |
2008-10-16 |
Boehringer Ingelheim International Gmbh |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
NZ582692A
(en)
|
2007-07-05 |
2012-05-25 |
Array Biopharma Inc |
Pyrimidyl cyclopentanes as akt protein kinase inhibitors
|
PL2578571T3
(pl)
|
2007-11-16 |
2016-03-31 |
Vertex Pharma |
Modulatory izochinolinowe transporterów zawierających kasetę wiążącą ATP
|
US8455514B2
(en)
|
2008-01-17 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-and 7-amino isoquinoline compounds and methods for making and using the same
|
US8450344B2
(en)
*
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
LT2318006T
(lt)
|
2008-08-15 |
2017-01-10 |
Nivalis Therapeutics, Inc. |
Nauji s-nitrozoglutationo reduktazės pirolo inhibitoriai, kaip terapiniai agentai
|
EP3828172A1
(en)
|
2009-05-01 |
2021-06-02 |
Aerie Pharmaceuticals, Inc. |
Dual mechanism inhibitors for the treatment of disease
|
ES2560603T3
(es)
|
2009-06-19 |
2016-02-22 |
D. Western Therapeutics Institute, Inc. |
Derivado de isoquinolina sustituida
|
WO2011085351A2
(en)
|
2010-01-11 |
2011-07-14 |
The Johns Hopkins University |
Method of treating kcnq related disorders
|
US20130296363A1
(en)
|
2010-09-01 |
2013-11-07 |
Ambit Biosciences Corporation |
Quinoline and isoquinoline derivatives for use as jak modulators
|
WO2012063237A2
(en)
|
2010-11-08 |
2012-05-18 |
Healor Ltd. |
Buffered ophthalmic compositions and methods of use thereof
|
TW201906614A
(zh)
*
|
2011-02-04 |
2019-02-16 |
日商興和股份有限公司 |
青光眼或高眼壓症之預防或治療用之點眼藥
|
JP2013035802A
(ja)
|
2011-08-10 |
2013-02-21 |
D Western Therapeutics Institute Inc |
緑内障又は高眼圧症の予防又は治療剤
|
EP2671883A1
(en)
|
2012-06-05 |
2013-12-11 |
Bioprojet |
New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands
|
JP2014019650A
(ja)
|
2012-07-13 |
2014-02-03 |
Santen Pharmaceut Co Ltd |
スルホンアミド化合物とタフルプロストの組み合わせ
|
WO2014019023A1
(en)
|
2012-08-01 |
2014-02-06 |
Bionomics Limited |
α7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF-I
|
CA2887598A1
(en)
|
2012-10-12 |
2014-04-17 |
Takeda Pharmaceutical Company Limited |
Cyclopropanamine compound and use thereof
|
EP3811943B1
(en)
|
2013-03-15 |
2023-02-22 |
Aerie Pharmaceuticals, Inc. |
Compound for use in the treatment of ocular disorders
|
JP2017522324A
(ja)
|
2014-07-17 |
2017-08-10 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
新規ナフチリジン及びイソキノリンならびにcdk8/19阻害剤としてのその使用
|
WO2016123627A1
(en)
|
2015-01-30 |
2016-08-04 |
Vanderbilt University |
Isoquiniline and napthalene-substituted compounds as mglur4 allosteric potentiators, compounds, and methods of treating neurological dysfunction
|
US9770466B2
(en)
|
2015-07-02 |
2017-09-26 |
Veloce Biopharma, Llc |
Ophthalmic composition and methods of use
|
US9643927B1
(en)
|
2015-11-17 |
2017-05-09 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
CA3033184A1
(en)
|
2016-08-19 |
2018-02-22 |
Aerie Pharmaceuticals, Inc. |
Beta-amino-isoquinolinyl amide compounds
|
US11389441B2
(en)
|
2016-08-31 |
2022-07-19 |
Aerie Pharmaceuticals, Inc. |
Ophthalmic compositions
|
MX2019011784A
(es)
|
2017-03-31 |
2019-11-18 |
Aerie Pharmaceuticals Inc |
Compuestos de aril ciclopropil-amino-isoquinolinil amida.
|
CN117050013A
(zh)
|
2018-03-30 |
2023-11-14 |
爱瑞制药公司 |
6-氨基异喹啉的单(酸)盐及其用途
|
EP3849555A4
(en)
|
2018-09-14 |
2022-05-04 |
Aerie Pharmaceuticals, Inc. |
ARYL CYCLOPROPYL AMINO ISOCHINOLINYL AMIDE COMPOUNDS
|